Not provided
Not provided
Not provided
Not provided
Not provided
Administratively closed early
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to assess early ambulation following total knee replacement in patients receiving continuous adductor canal block with posterior capsular injection compared to continuous femoral nerve block with tibial nerve block.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Canal Block and Capsular Injection | Experimental | Adductor canal block with a continuous catheter and ultrasound guided posterior capsular injection with local anesthetic solution. |
|
| Femoral with Tibial Nerve Block | Active Comparator | Continuous femoral nerve block with catheter and selective tibial nerve block in the popliteal fossa. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Canal Block and Capsular Injection | Procedure | Continuous Adductor canal block with 15ml of ropivacaine 0.2% with epinephrine 1:400,000 followed by an infusion of ropivacaine 0.2% at 6ml per hour for 2 days post operatively. This is combined with ultrasound guided posterior capsular knee injection with 30ml ropivacaine 0.2% with epinephrine 1:400,000. |
| Measure | Description | Time Frame |
|---|---|---|
| Ability to ambulate post operatively. | Ability to ambulate and perform tasks of the rehabilitation program and reach rehabilitation milestones after total knee arthroplasty. | Up to 3 days (72 hours) post surgery. |
| Measure | Description | Time Frame |
|---|---|---|
| Pain scores at rest and with knee flexion. | Measures of pain score using numeric pain rating scale (0=no pain, 10=worst pain) completed by patient in recovery room and every 6 hours for a 72 hour period after discharge from recovery room. | Up to 3 days ( 72 hours) after surgery |
| Pain Medication Consumption |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sanjay Sinha, M.D. | Saint Francis Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Saint Francis Hospital and Medical Center | Hartford | Connecticut | 06105 | United States |
Not provided
| ID | Term |
|---|---|
| D010146 | Pain |
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001168 | Arthritis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Femoral Nerve Block with Tibial Nerve Block | Procedure | Continuous femoral nerve block with 15ml of ropivacaine 0.2% followed by an infusion of ropivacaine 0.2% at 6ml per hour for 2 days after surgery combined with tibial nerve block in the popliteal fossa with ropivacaine 0.5% up to 15ml. |
|
Amount of opioid consumption post surgery for 72 hours. |
| Up to 3 days (72 hours) post surgery |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |